We are live on ! Find out more
DA

Dunvegan Associates Portfolio holdings

AUM $85.1M
1-Year Est. Return 2.3%
This Fund
S&P 500
This Quarter Est. Return
+3.98%
1 Year Est. Return
-2.3%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$119M
AUM Growth
-$2.39M
Cap. Flow
-$3.06M
Cap. Flow %
-2.58%
Top 10 Hldgs %
49.96%
Holding
224
New
153
Increased
5
Reduced
49
Closed
8

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$6.01M
2
LNG icon
Cheniere Energy
LNG
+$918K
3
V icon
Visa
V
+$252K
4
CBI
Chicago Bridge & Iron Nv
CBI
+$172K
5
AAPL icon
Apple
AAPL
+$149K

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$3.83M
2
GLD icon
SPDR Gold Trust
GLD
+$1.84M
3
NVO
Novo Nordisk
NVO
+$1.27M
4
GEB.CL
General Electric Capital Corp
GEB.CL
+$1.05M
5
SCHW.PRB.CL
The Charles Schwab Corporation
SCHW.PRB.CL
+$755K

Sector Composition

Rank Sector Weight
1 Energy 22.96%
2 Miscellaneous 20.37%
3 Financials 13.71%
4 Healthcare 11.87%
5 Consumer Staples 10.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MA icon
1
Mastercard
MA
$521B
$10.4M 8.76%
139,365
-5,145
-4% -$402K
LNG icon
2
Cheniere Energy
LNG
$58.3B
$7.55M 6.35%
136,417
+19,144
+16% +$918K
GLD icon
3
SPDR Gold Trust
GLD
$149B
$7.11M 5.98%
57,494
-14,740
-20% -$1.84M
MKC icon
4
McCormick & Company Non-Voting
MKC
$14.9B
$7.06M 5.94%
196,804
-15,422
-7% -$519K
WPZ
5
DELISTED
Williams Partners L.P.
WPZ
$5.71M 4.8%
105,243
-12,365
-11% -$654K
MON
6
DELISTED
Monsanto Co
MON
$5.32M 4.48%
46,797
-3,708
-7% -$413K
V icon
7
Visa
V
$712B
$5.03M 4.23%
93,152
+4,532
+5% +$252K
NVS icon
8
Novartis
NVS
$292B
$4.06M 3.42%
53,333
-5,001
-9% -$364K
AGN
9
DELISTED
Allergan plc
AGN
$3.77M 3.17%
+30,358
New +$6.01M
ENB icon
10
Enbridge
ENB
$110B
$3.35M 2.82%
73,595
-6,657
-8% -$287K
LLY icon
11
Eli Lilly
LLY
$1.05T
$2.78M 2.34%
47,158
-4,061
-8% -$227K
ACN icon
12
Accenture
ACN
$116B
$2.62M 2.21%
32,859
-37
-0.1% -$3.04K
TRP icon
13
TC Energy
TRP
$64.4B
$2.56M 2.16%
56,320
-5,403
-9% -$240K
AMLP icon
14
Alerian MLP ETF
AMLP
$13.4B
$2.48M 2.08%
28,045
-2,448
-8% -$215K
IRL
15
DELISTED
NEW IRELAND FUND INC
IRL
$2.34M 1.97%
162,722
-607
-0.4% -$8.28K
UPS icon
16
United Parcel Service
UPS
$89.6B
$2.27M 1.91%
23,356
-2,713
-10% -$264K
MMM icon
17
3M
MMM
$89.9B
$2.18M 1.83%
19,214
-857
-4% -$95.2K
CLR
18
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$2.11M 1.77%
33,942
-3,128
-8% -$178K
ABEV icon
19
Ambev
ABEV
$44.1B
$2.06M 1.73%
277,270
-3,105
-1% -$21.7K
EWI icon
20
iShares MSCI Italy ETF
EWI
$1.12B
$2M 1.68%
56,368
-4,727
-8% -$155K
IBB icon
21
iShares Biotechnology ETF
IBB
$10.5B
$1.93M 1.62%
24,471
-3,267
-12% -$272K
TEF
22
DELISTED
Telefonica
TEF
$1.87M 1.57%
161,242
+1,609
+1% +$18.5K
MOS icon
23
The Mosaic Company
MOS
$7.5B
$1.84M 1.55%
36,813
-680
-2% -$32.4K
UGP icon
24
Ultrapar
UGP
$6.87B
$1.78M 1.5%
147,852
-7,974
-5% -$88.8K
SGF
25
DELISTED
Aberdeen Singapore Fund
SGF
$1.71M 1.44%
136,952
+1,240
+0.9% +$15.2K
1
2 3 4 5

Similar funds

TSBJ
Trevor, Stewart, Burton & Jacobsen New York $88.4M AUM 7.43% 1-Year Est. Return
VCAM
Valentine Capital Asset Management Danville, California $89.6M AUM 0.84% 1-Year Est. Return
KCA
KR Capital Advisors New York $80M AUM 4.21% 1-Year Est. Return
TP
TB Partners Shanghai, China $90.9M AUM
SPC
Standard Pacific Capital San Francisco, California $92M AUM 5.65% 1-Year Est. Return
ST
Semper Trust King Of Prussia, Pennsylvania $71.9M AUM
CGC
Cloud Gate Capital Chicago, Illinois $70.7M AUM 11.83% 1-Year Est. Return
GCG
Giovine Capital Group Santa Monica, California $68.7M AUM 2.56% 1-Year Est. Return

Dunvegan Associates's Q1 2014 Portfolio in Review

As of Q1 2014, Dunvegan Associates held 224 positions worth $119M, down 2% from $121M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Dunvegan Associates's Q1 2014 filing shows 153 new, 5 increased, 49 reduced and 8 closed positions. Its largest new stake was Allergan plc: 30,358 shares worth $3.77M. The largest sale was Allergan Inc, an estimated $3.83M.

By sector, the portfolio is most concentrated in Energy at 23% of assets, up from 21% a quarter earlier, followed by Miscellaneous and Financials.

  • Dunvegan Associates's largest Q1 2014 buy was Allergan plc: 30,358 shares worth $3.77M.
  • Dunvegan Associates added most to Cheniere Energy in Q1 2014, an estimated $918K increase.
  • Dunvegan Associates's biggest Q1 2014 reduction was SPDR Gold Trust, cutting an estimated $1.84M.
  • Dunvegan Associates fully exited Allergan Inc in Q1 2014, selling an estimated $3.83M.
  • Dunvegan Associates's ten largest holdings make up 50% of its $119M portfolio in Q1 2014.
  • Dunvegan Associates opened 153 new positions and closed 8 in Q1 2014.
  • Dunvegan Associates's portfolio value fell 2% quarter-over-quarter to $119M.

Based on Dunvegan Associates's 13F filing for Q1 2014, filed 28 Apr 2017.